Confirmed Objective Response Rate (cORR): the percentage of patients ... of time a patient responds to treatment without their cancer growing or spreading. New Drug Application (NDA): a request to ...
Growing body of clinical evidence supports use of Company’s FDA-Cleared BNA™ platform to provide objective measures of drug efficacy and ...
The US Food and Drug Administration (FDA) recently issued its draft guidance, Considerations for the Use of Artificial Intelligence to ...
NDAQ:ZLAB) Zai Lab Receives Orphan Drug Designation from the U.S. FDA for ZL-1310 (DLL3 ADC) for the Treatment of Small Cell ...
With Donald Trump as the new US president, pundits are speculating about how US policy towards Latin America might change. By ...
Inflammation serves as a biological response to harmful stimuli, playing a crucial role in bodily defense but also leading to various chronic conditions ...
ZILRETTA and iovera°; the related timing and success of U.S. Food and Drug Administration supplemental New Drug Applications and premarket notification 510(k)s; the related timing and success of ...
The Readi Collect System Readi Collect Endorsement by Intellenet Coverage Map Introducing a groundbreaking solution for compa ...
Hallucinations in LLMs refer to instances where models generate plausible yet incorrect or unrelated information.
The FDA approves AstraZeneca's sBLA for Enhertu to treat HER2-low or HER2-ultralow metastatic breast cancer in the United ...
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that the U.S. Food and Drug Administration (FDA) has accepted ...
January 17, 2025--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that China’s National Medical Products Administration (NMPA) has accepted the New Drug Application ...